4.9989
price up icon1.20%   0.0111
 
loading
Rezolute Inc stock is traded at $4.9989, with a volume of 28,691. It is up +1.20% in the last 24 hours and up +3.68% over the past month. Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.
See More
Previous Close:
$5.01
Open:
$5
24h Volume:
28,691
Relative Volume:
0.07
Market Cap:
$279.08M
Revenue:
-
Net Income/Loss:
$-68.46M
P/E Ratio:
-4.9989
EPS:
-1
Net Cash Flow:
$-57.37M
1W Performance:
-9.46%
1M Performance:
+3.68%
6M Performance:
+69.00%
1Y Performance:
+530.28%
1-Day Range:
Value
$4.95
$5.14
1-Week Range:
Value
$4.66
$5.74
52-Week Range:
Value
$0.72
$6.1856

Rezolute Inc Stock (RZLT) Company Profile

Name
Name
Rezolute Inc
Name
Phone
650-206-4507
Name
Address
275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY
Name
Employee
59
Name
Twitter
Name
Next Earnings Date
2024-11-11
Name
Latest SEC Filings
Name
RZLT's Discussions on Twitter

Compare RZLT with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
RZLT 4.95 279.08M 0 -68.46M -57.37M -1.00
VRTX 448.09 115.74B 10.63B -479.80M -1.35B 13.33
REGN 742.00 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 590.72 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 249.31 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 102.52 24.49B 3.30B -501.07M 1.03B 11.54

Rezolute Inc Stock (RZLT) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-02-22 Resumed Canaccord Genuity Buy
Jun-15-22 Initiated Cantor Fitzgerald Overweight
Sep-08-21 Initiated ROTH Capital Buy
May-27-21 Initiated Oppenheimer Outperform
May-25-21 Initiated H.C. Wainwright Buy

Rezolute Inc Stock (RZLT) Latest News

pulisher
Nov 20, 2024

Wedbush Initiates Coverage of Rezolute (RZLT) with Outperform Recommendation - MSN

Nov 20, 2024
pulisher
Nov 19, 2024

(RZLT) On The My Stocks Page - Stock Traders Daily

Nov 19, 2024
pulisher
Nov 18, 2024

Institutional investors in Rezolute, Inc. (NASDAQ:RZLT) lost 11% last week but have reaped the benefits of longer-term growth - Simply Wall St

Nov 18, 2024
pulisher
Nov 16, 2024

Is Rezolute, Inc. (RZLT) the Best Multibagger Stock to Buy Heading into 2025? - Yahoo Finance

Nov 16, 2024
pulisher
Nov 14, 2024

10 Best Multibagger Stocks To Buy Heading into 2025 - Insider Monkey

Nov 14, 2024
pulisher
Nov 14, 2024

Rezolute's SWOT analysis: biotech stock eyes growth amid clinical progress - Investing.com India

Nov 14, 2024
pulisher
Nov 13, 2024

We Think Rezolute (NASDAQ:RZLT) Needs To Drive Business Growth Carefully - Yahoo Finance

Nov 13, 2024
pulisher
Nov 11, 2024

Rezolute stock soars to 52-week high, hits $6.1 amid surge By Investing.com - Investing.com South Africa

Nov 11, 2024
pulisher
Nov 11, 2024

Rezolute stock soars to 52-week high, hits $6.1 amid surge - Investing.com India

Nov 11, 2024
pulisher
Nov 08, 2024

(RZLT) Investment Report - Stock Traders Daily

Nov 08, 2024
pulisher
Nov 08, 2024

Rezolute (NASDAQ:RZLT) Earns "Buy" Rating from HC Wainwright - MarketBeat

Nov 08, 2024
pulisher
Nov 07, 2024

Rezolute Reports First Quarter Fiscal 2025 Financial Results and Provides Business Update - The Manila Times

Nov 07, 2024
pulisher
Nov 07, 2024

Rezolute Advances Phase 3 Trials Despite $15.4M Loss; Maintains $117.8M Cash Position | RZLT Stock News - StockTitan

Nov 07, 2024
pulisher
Nov 07, 2024

Equities Analysts Offer Predictions for Rezolute Q1 Earnings - MarketBeat

Nov 07, 2024
pulisher
Nov 06, 2024

Wedbush Reaffirms “Outperform” Rating for Rezolute (NASDAQ:RZLT) - Defense World

Nov 06, 2024
pulisher
Nov 05, 2024

Rezolute to Participate in Upcoming Investor Conferences - The Manila Times

Nov 05, 2024
pulisher
Nov 04, 2024

Rezolute (NASDAQ:RZLT) Given Outperform Rating at Wedbush - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

Rezolute, Inc. (NASDAQ:RZLT) Receives $11.57 Consensus Target Price from Analysts - Defense World

Nov 04, 2024
pulisher
Nov 01, 2024

Rezolute, Inc. (NASDAQ:RZLT) Receives $11.57 Average Price Target from Brokerages - MarketBeat

Nov 01, 2024
pulisher
Oct 29, 2024

(RZLT) Technical Pivots with Risk Controls - Stock Traders Daily

Oct 29, 2024
pulisher
Oct 21, 2024

SEC Form DEFA14A filed by Rezolute Inc. - Quantisnow

Oct 21, 2024
pulisher
Oct 20, 2024

AAO 2024: Rezolute’s RZ-402 shows promising Phase IIa results in DME patients - Yahoo Finance

Oct 20, 2024
pulisher
Oct 17, 2024

With 62% ownership, Rezolute, Inc. (NASDAQ:RZLT) boasts of strong institutional backing - Yahoo Finance

Oct 17, 2024
pulisher
Oct 15, 2024

Cubist Systematic Strategies LLC Boosts Stock Holdings in Rezolute, Inc. (NASDAQ:RZLT) - Defense World

Oct 15, 2024
pulisher
Oct 11, 2024

Azitra to Participate in the 2024 Maxim Healthcare Virtual Summit - StockTitan

Oct 11, 2024
pulisher
Oct 08, 2024

Renaissance Technologies LLC Sells 149,660 Shares of Rezolute, Inc. (NASDAQ:RZLT) - MarketBeat

Oct 08, 2024
pulisher
Oct 07, 2024

Rezolute, Inc. (NASDAQ:RZLT) Receives Average Recommendation of "Buy" from Analysts - MarketBeat

Oct 07, 2024
pulisher
Oct 06, 2024

Rezolute, Inc. (NASDAQ:RZLT) Shares Acquired by Cubist Systematic Strategies LLC - Defense World

Oct 06, 2024
pulisher
Oct 02, 2024

Marshall Wace LLP Invests $4.50 Million in Rezolute, Inc. (NASDAQ:RZLT) - MarketBeat

Oct 02, 2024
pulisher
Oct 02, 2024

Continuing Rare Disease Treatment With A Compassionate Use Program (CUP) - Clinical Leader

Oct 02, 2024
pulisher
Oct 01, 2024

Nantahala Capital Management LLC Cuts Holdings in Rezolute, Inc. (NASDAQ:RZLT) - Defense World

Oct 01, 2024
pulisher
Oct 01, 2024

XTX Topco Ltd Has $145,000 Holdings in Rezolute, Inc. (NASDAQ:RZLT) - Defense World

Oct 01, 2024
pulisher
Sep 30, 2024

Rezolute's SWOT analysis: biotech firm's stock poised for growth amid clinical trials - Investing.com

Sep 30, 2024
pulisher
Sep 28, 2024

Rezolute, Inc. (NASDAQ:RZLT) Short Interest Update - MarketBeat

Sep 28, 2024
pulisher
Sep 27, 2024

Rezolute (NASDAQ:RZLT) Receives Buy Rating from HC Wainwright - MarketBeat

Sep 27, 2024
pulisher
Sep 26, 2024

Rezolute Inc: Buy, Hold, or Sell? Analysts Weigh In Amid Market Challenges - The InvestChronicle

Sep 26, 2024
pulisher
Sep 26, 2024

Rezolute Inc [RZLT] stock for 20,017 USD was acquired by Hogenhuis Wladimir - Knox Daily

Sep 26, 2024
pulisher
Sep 25, 2024

Director Wladimir Hogenhuis Acquires 4,259 Shares of Rezolute In - GuruFocus.com

Sep 25, 2024
pulisher
Sep 25, 2024

Affinity Asset Advisors LLC Acquires 250,000 Shares of Rezolute, Inc. (NASDAQ:RZLT) - Defense World

Sep 25, 2024
pulisher
Sep 25, 2024

Affinity Asset Advisors LLC Purchases 250,000 Shares of Rezolute, Inc. (NASDAQ:RZLT) - MarketBeat

Sep 25, 2024
pulisher
Sep 25, 2024

Rezolute executive Wladimir Hogenhuis buys $20,017 in company stock By Investing.com - Investing.com Australia

Sep 25, 2024
pulisher
Sep 24, 2024

Rezolute, Inc. (NASDAQ:RZLT) Director Wladimir Hogenhuis Buys 4,259 Shares - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Rezolute executive Wladimir Hogenhuis buys $20,017 in company stock - Investing.com

Sep 24, 2024
pulisher
Sep 21, 2024

US FDA lifts partial clinical hold on Rezolute's low blood sugar treatment - MSN

Sep 21, 2024
pulisher
Sep 20, 2024

BTIG bullish on Rezolute stock as pivotal trials move forward and hold lifted - Investing.com Canada

Sep 20, 2024
pulisher
Sep 20, 2024

Rezolute Inc [RZLT] Director makes an insider acquire of 4,815 shares worth 19,982. - Knox Daily

Sep 20, 2024
pulisher
Sep 20, 2024

Rezolute (NASDAQ:RZLT) Releases Quarterly Earnings Results, Misses Estimates By $0.14 EPS - Defense World

Sep 20, 2024
pulisher
Sep 20, 2024

JMP Securities Reaffirms "Market Outperform" Rating for Rezolute (NASDAQ:RZLT) - MarketBeat

Sep 20, 2024
pulisher
Sep 20, 2024

JMP Securities Reiterates “Market Outperform” Rating for Rezolute (NASDAQ:RZLT) - Defense World

Sep 20, 2024
pulisher
Sep 20, 2024

Rezolute (NASDAQ:RZLT) Releases Earnings Results, Misses Expectations By $0.14 EPS - MarketBeat

Sep 20, 2024
pulisher
Sep 20, 2024

Rezolute Inc (RZLT) stock analysis: A simple moving average approach - US Post News

Sep 20, 2024

Rezolute Inc Stock (RZLT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Rezolute Inc Stock (RZLT) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Hogenhuis Wladimir
Director
Jun 25 '24
Buy
4.15
4,815
19,982
37,508
ROBERTS BRIAN KENNETH
Chief Medical Officer
Jun 14 '24
Buy
3.91
4,300
16,828
54,352
ROBERTS BRIAN KENNETH
Chief Medical Officer
Jun 14 '24
Buy
3.91
3,300
12,916
13,000
Evans Daron
CFO
Jun 14 '24
Buy
4.04
40,000
161,568
40,000
Evans Daron
CFO
May 29 '24
Buy
3.50
451
1,578
121,351
ROBERTS BRIAN KENNETH
Chief Medical Officer
May 23 '24
Buy
2.69
7,500
20,138
50,052
Evans Daron
CFO
May 24 '24
Buy
3.23
2,942
9,503
13,000
Evans Daron
CFO
May 23 '24
Buy
2.85
58
165
10,058
ROBERTS BRIAN KENNETH
Chief Medical Officer
Mar 28 '24
Buy
2.55
500
1,275
1,076
Evans Daron
CFO
Mar 15 '24
Buy
1.69
20,000
33,830
20,000
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Cap:     |  Volume (24h):